Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Parkinson's Disease
 More »

  • AbbVie Expands Galapagos Collaboration to Include Crohn's Disease
    ... include hepatitis C, rheumatoid arthritis, psoriasis, multiple sclerosis, Alzheimer's disease, Parkinson's disease, axial spondyloarthritis, multiple myeloma, and endometriosis. ...
    5-17-2013
  • Harnessing the Power of Kinase Inhibitors
    ... like asthma, IBD, and rheumatoid arthritis, and LRRK2, a key kinase active in the brain in Parkinson's disease. These and other inhibitors are currently being examined in vivo. ...
    5-8-2013
  • Is Brain Mapping Ready for Big Science?
    ... And project proponents say the only way to tackle some thus far tricky intractable human diseases, like Alzheimer's and Parkinson's disease, is with a huge program. "We are right ...
    5-1-2013
  • GSK Parts Ways with Impax
    Impax Pharmaceuticals said today it will end co-development with GlaxoSmithKline of IPX066 outside Taiwan and the U.S., where the Parkinson's disease drug candidate is called ...
    4-29-2013
  • Potential Prion Disease Therapy Uncovered
    diseases such as Alzheimer's, Parkinson's, and Huntington's diseases," she says. ... new approach to treat Alzheimer's disease, which is characterized by the build-up ...
    4-4-2013
  • KannaLife in R&D Collaboration for Cannabinoid-Based Drugs
    damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and HIV dementia. ...
    4-4-2013
  • Is This Gene Therapy's Breakout Moment?
    The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. Its pipeline as of June included the Parkinson's disease application AAV-hAADC in Phase II, the ...
    4-1-2013
  • Predicting Drug Toxicity in Humans
    induced pluripotent stem cells [iPS]) to yield cardiomyocytes or Parkinson's neurons. ... toxicity and sensitivity profiles, and disease signatures. "Mitosafe is for early ...
    4-1-2013
  • Is Brain Mapping Ready for Big Science?
    ... And project proponents say the only way to tackle some thus far tricky intractable human diseases, like Alzheimer's and Parkinson's disease, is with a huge program. "We are right ...
    3-27-2013
  • Merck Sells COMT Inhibitor Rights to Cerecor
    Drugs that inhibit COMT have been used to treat patients with Parkinson's disease; however, they reportedly have poor brain penetration and limited safety and tolerability. But ...
    3-20-2013
  • Can Fat Fight Brain Cancer?
    ... MSCs, whether derived from bone marrow or fat, have been studied in animal models to treat trauma, Parkinson's disease, ALS, and other diseases. Results of this Johns Hopkins ...
    3-12-2013
  • Avanir to Screen Veterans for Pseudobulbar Affect Symptoms
    PBA occurs when a TBI or other neurological condition, such as multiple sclerosis, Lou Gehrig's disease, Parkinson's disease, stroke, or Alzheimer's disease, damages the areas of ...
    3-6-2013
  • Is This Gene Therapy's Breakout Moment?
    The most advanced such programs have been overseen by Sanofi's Genzyme subsidiary. Its pipeline as of June included the Parkinson's disease application AAV-hAADC in Phase II, the ...
    3-4-2013
  • Zapping Pathological Proteins in Alzheimer's
    These abnormal proteins are associated with about 20 human diseases including Alzheimer's, Huntington's, Parkinson's, and Creutzfeldt-Jakob disease. The body's immune system does ...
    3-1-2013
  • Small Firms Look Optimistically to Future
    ... the immunogenicity of enzyme replacement therapy. "We have Phase II data in Fabry and Pompe diseases, and are in late preclinical development targeting Parkinson's disease. ...
    3-1-2013
  • More »

    Journal Articles

  • Telemonitoring and Telerehabilitation of Patients with Parkinson...
    Daniele Giansanti, Velio Macellari, Giovanni Maccioni
    Telemedicine and e-Health
    Telemonitoring and Telerehabilitation of Patients with Parkinson's Disease: Health Technology Assessment of a Novel Wearable Step Counter Telemedicine and e-Health Measurement of ...
  • Protective Effects of Neurotrophic Factor-Secreting Cells in...
    Ofer Sadan, Merav Bahat-Stromza, Yael Barhum, Yossef S. Levy, Anat Pisnevsky, Hagit Peretz, Avihay Bar Ilan, Shlomo Bulvik, Noam Shemesh, Dana Krepel, Yoram Cohen, Eldad Melamed, Daniel Offen
    Stem Cells and Development
    An efficacy study was conducted on the 6-OHDA-induced lesion, a rat model of Parkinson's disease. The cells, either MSC or NTF-SC, were transplanted on the day of 6-OHDA ...
  • Human Amniotic Fluid Stem Cells Do Not Differentiate Into Dopamine...
    Angela E. Donaldson, Jingli Cai, Ming Yang, Lorraine Iacovitti
    Stem Cells and Development
    Although embryonic stem (ES) cells can generate dopamine (DA) neurons that are potentially useful as a cell replacement therapy in Parkinson's disease (PD), associated ethical and ...
  • Enriched NCAM-Positive Cells Form Functional Dopaminergic Neurons...
    Geeta Ravindran, Harinarayana S. Rao
    Stem Cells and Development
    Enriched NCAM-Positive Cells Form Functional Dopaminergic Neurons in the Rat Model of Parkinson's Disease Stem Cells and Development We describe a method of generating an enriched ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll